Overview

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate in lung or heart-lung transplant patients on tacrolimus and mycophenolate the impact of optimized mofetil (MMF) therapeutic drug monitoring and dose adjustment of both drugs on the incidence of treatment failure over the first three years post-transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Limoges
Treatments:
Immunosuppressive Agents
Tacrolimus